## Abstract ^14^C‐Labelled (S)‐(+)‐6‐(2‐chlorophenyl)‐3‐cyclopropanecarbonyl‐8,11‐dimethyl‐2,3,4,5‐ tetrahydro‐8H‐pyrido[4′,3′:4,5]thieno[3,2‐f][1,2,4]triazolo[4,3‐a][1,4] diazepine (^14^C‐E6123), a platelet activating factor receptor antagonist for studying the pharmacokinetic profile of E6123, wa
First total synthesis of a new sesquiterpenoid natural product, (±)-3-(2,4-dihydroxybenzoyl)-4,5-dimethyl-5-(4,8-dimethyl-3(E),7(E)-nonadien-1-yl)tetrahydro-2-furanone
✍ Scribed by Hidemi Yoda; Kazuhide Maruyama; Kunihiko Takabe
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- French
- Weight
- 113 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0040-4039
No coin nor oath required. For personal study only.
✦ Synopsis
An efficient and stereodefined process is described for the first preparation of a new prenyl-benzoylfuranone type sesquiterpenoid, (±)-3-(2,4-dihydroxybenzoyl)-4,5-dimethyl-5-(4,8-dimethyl-3(E),7(E)-nonadien-1-yl)tetrahydro-2-furanone. The synthetic strategy is based on nucleophilic addition of organometallic reagents to the functionalized ketoamides elaborated from dihydroxyacetone dimer for the stereoselective construction of the key quaternary carbon center in the target compound.
📜 SIMILAR VOLUMES
## Abstract The now corrected X‐ray structure of (2__R__)‐bornane‐10,2‐sultam ((−)‐**1a**), as well as that of its already published __N__‐crotonoyl derivative (−)‐**1d**, were compared with those of the newly synthesized (2__R__)‐fenchane‐8,2‐sultam ((+)‐**5a**), as well as its __N__‐crotonoyl der